知镜 Cognispect · 医学文献与研究工作台

Impact of online versus in-person management of atopic dermatitis on QOL and access to care: A randomized controlled trial.

Armstrong AW, Roberts AM, Kostandy G, Choudhury F, Yee D, Luu M, Jones ME, Alizadeh ER, Cotliar J, Chren MM, Gelfand JM, Cockburn M, Doctor JN.
The Journal of investigative dermatology · 2026-06-26 · PMID 42362079

文献摘要

Background Atopic dermatitis is a chronic skin disease that can significantly affect quality of life (QOL) and requires regular access to dermatologic care. However, traditional in-person visits often impose logistical challenges. Objectives The aim of this study was to evaluate whether an online, team-based connected health teledermatology model provides improvements in QOL equivalent to those provided by in-person management of atopic dermatitis and to examine access to care. Methods We conducted a 12-month, pragmatic, randomized, controlled equivalence trial (NCT03981926) involving 300 participants aged ≥1 year with physician-diagnosed atopic dermatitis. Participants were randomized 1:1 to the online or in-person arm. QOL was assessed using the Dermatology Life Quality Index and EQ-5D-5L. Access was measured through the average time needed for evaluation. Results For all QOL measures, the difference in mean change between arms fell within the prespecified equivalence margins: 0.12 (95% confidence interval = -0.18 to 0.42) for Dermatology Life Quality Index, 0.00 (95% confidence interval = -0.01 to 0.01) for utility index, and -0.11 (95% confidence interval = -0.70 to 0.48) for Visual Analog Scale. Team-based connected health significantly reduced the time needed for evaluation at baseline (P = .03). Conclusion For patients with atopic dermatitis, the online team-based connected health model resulted in equivalent improvements in QOL and reduced the time needed for evaluation at baseline.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。